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Evidence ispresented for specific enzymatic methylation of 21-23 kDa membrane proteins in intact neuroblastoma NlE 115 cells, which is’increased 
in dimethylsulfoxide-induced differentiated cells. Methylation of these proteins has characteristics typical of enzymatic reactions in which base labile 
volatile methyl groups are incorporated into proteins, consistent with the formation of protein carboxyl methylesters. However, these methylesters 
of the 21-23 kDa proteins are relatively stable compared to other protein carboxyl methylesters. The 3-fold increase in methylated 21-23 kDa 
proteins in the differentiated cells suggest biological significance in differentiation of the cell membranes. 
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1. INTRODUCTION 
Methylation of protein carboxyl groups is one type of 
post-translational modification by which structure and 
function of proteins can be regulated. Enzymes that 
catalyze these reactions utilize Sadenosyl-L-methio- 
nine as a methyl donor to form protein carboxyl 
methylesters [ 1,2]. One of these enzymes is a bacterial 
methyltransferase which methylates L-glutamate 
residues of membrane chemoreceptors to modulate 
their signaling functions [3-51. A second methyltrans- 
ferase, which is abundant in eukaryotic cells, methyl- 
ates abnormal D-aspartyl or L-isoaspartyl residues and 
may function in the repair of age-damaged proteins 
[6,7]. The products of this enzyme are highly unstable, 
rapidly hydrolyzed, protein carboxyl methylesters. It is 
not known whether the rapidly reversible protein 
methylations, which were implicated in several cellular 
functions, e.g. hormone secretion [8], cell motility [9] 
and differentiation [lo, 111, reflect this type of protein 
methylation in eukaryotic cells. A third type of protein 
methyltransferase appears to be an enzyme which forms 
the C-terminal cysteinyl Lu-carboxymethylesters of some 
fungal peptidyl sex factors [ 121, several ras proteins 
[13,14] and certain unidentified 23-29 kDa proteins of 
bovine rod outer segments [151. 
The cGMP phosphodiesterase in bovine rod outer 
segments [16] and the nuclear lamin B [17] as well as 
certain membrane proteins of mouse macrophage RAW 
264 cells [18], are also carboxyl methylated proteins 
whose methyl esters show the relatively high stability 
seen with ras proteins. Here we report on another group 
of relatively stable 21-23 kDa protein methylesters, 
which are formed in the membranes of mouse 
neuroblastoma NlE 115 cells, and show that these pro- 
tein methylesters are increased in differentiated cells. 
2. MATERIALS AND METHODS 
Correspondence address: Y. Kloog, Department of Biochemistry, 
The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel 
Aviv 69978, Israel 
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; FCS, 
fetal calf serum; DMSO, dimethylsulfoxide; PBS, phosphate buf- 
fered saline; EDTA, ethylenediaminetetra-acetic acid; SDS, sodium 
dodecyl sulfate 
Cells of mouse neuroblastoma clone NlE 115 were routinely grown 
in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% 
fetal calf serum (FCS) at 37°C in a humidified atmosphere of 5% 
C02/95% air, as described previously [ 111. The cells were plated at a 
density of 2.104 cells/cm’ in 75 cm2 tissue culture flasks. Media were 
replaced one day after plating, three days after plating and daily 
thereafter. Control (undifferentiated cells) received only DMEM 
+ FCS. The dimethylsulfoxide (DMSO)-treated cultures (differen- 
tiated cells) were fed with DMEM + FCS containing 2% DMSO, 
starting one day after plating. The control cells continued to multiply 
and reached confluence by 5-6 days in culture. The DMSO-treated 
cells stopped multiplication and extended processes everal days (4-S) 
after plating, in line with previous reports [11,19]. Cells were in- 
cubated at 37°C in 2.5 ml DMEM (without methionine) containing 
250&i [methyl-‘Hlmethionine (15 CVmmol. New England Nuclear). 
After 60 min the medium was discarded, cells were washed 4 x with 
15 ml of phosphate buffered saline (PBS) and detached in PBS con- 
taining 5 mM ethylenediaminetetra-acetic acid (EDTA). The detached 
cells were collected by centrifugation (1000 x g for 5 mitt), and the 
pelleted cells were resuspended (in 500~1 of 20 mM phosphate buffer, 
pH 7.5, containing 5 mM EDTA and 5 mM fl-mercaptoethanol) and 
sonicated for 20 s. The homogenates contained 0.7-l mg protein per 
ml. Particulate and cytosolic fractions were separated by centrifuga- 
tion (100 000 x g x 1 h). In each experiment 50-70~1 of sample con- 
taming the same amount of protein from control cell homogenates or 
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DMSO-treated c llhomogenates, or similar amounts of proteins from 
subcellular fractions, were loaded onto slab gels. 
Protein carboxyl methylesters were determined after elec- 
trophoresis on 12.5% polyac~lamide sodium dodecylsulfate (SDS) 
slab gels (pH 8.5) according to Laemmli 1201. The gels were 
Coomassie blue stained, dried, sectioned (2 mm sections) and sub- 
jected to the vapor phase equilibrium assay as described by Chelsky 
et al. [17]. 
3. RESULTS 
Confluent neuroblastoma cells (7 days in culture) 
were incubated in a methionine free DMEM for 1 h with 
[methyl-3H]methionine, the precursor for the methyl 
donor 4adenosyl-L-methionine. Incorporation of 
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Fig.1. Methylation of confluent neuroblastoma NlE 115 cells’ pro- 
teins. Cells were labeled with [methyl-‘H] methionine for 1 h in the 
absence (0) or in the presence (0) of 100 FM 3-deaza-adenosine and 
100 FM ~om~ysteine thiolactone (A and B) or for 1 h with 
[methyl-3H~methion~e which was followed by a chase with DMEM 
for the indicated periods of time (C). Proteins from whole cells (A) or 
from their membrane fraction (B) were separated on SDS 
polyacrylamide slab gels and protein methylesters determined as 
described in section 2. Molecular mass standards (kDa) were elec- 
trophoresed in separate lanes in each experiment and their migration 
distance is indicated by arrows. T.D., tracking dye. Turnover of the 
major peak of the 21-23 kDa proteins is shown in C; data are express- 
ed as percentage of the methylation at zero time. 
[methyl-3H] groups was assayed by the vapor-phase 
equilibrium assay after separating the proteins by SDS 
polya~~l~ide gels, pH 8.5. This assay specifically 
detects protein carboxyl methylesters that are degraded 
by base (1 N NaOH) to yield volatile methanol [ 171. A 
typical experiment with the confluent NIE 115 cells 
(fig.lA) detected a major group of peaks containing 
base labile volatile radioactivity at A4, 21-23 kDa and 
minor peaks at M, 33-36 kDa. Incorporation of 
[methyl-3H] groups into the proteins was strongly in- 
hibited by the known methylation inhibitors 3-deaza- 
adenosine and homocysteine thiolactone (fig.lA), in- 
dicating that they were methylated by a specific 
transmethylation reaction. The major group of the 
neuroblastoma methylated proteins, viz. the 21-23 kDa 
proteins, were found to be associated with the cell mem- 
brane; more than 90% of these methyl-labeled proteins 
were detected in the particulate fraction (fig.lB). 
Methylester radioactivity in the membranes was not 
removed by extensive washings or treatment with 1 M 
NaCl (table 1). Treatment with the nonionic detergent 
nonidet NP-40 (1%) did, however, release the 21-23 
kDa methylated proteins from the membranes (table 1). 
Other experiments confirmed the base lability and 
volatility of the [methyl-3H] groups in the 21-23 kDa 
proteins, yet aiso demonstrated their relatively high 
stability: (i) exposure of the dried gel bands contai~ng 
the 21-23 kDa proteins to 1 N NaOH for 24 h and dry- 
ing down at room temperature prior to the base/vapor 
phase equilibrium assay resulted in a total loss of the 
radioactivity (from 2760 dpm to 30 dpm); (ii) in a 
similar experiment with exposure to Tris buffer, pH 
8.5, no loss of radioa~ivity was observed (2680 dpm); 
(iii) exposure of the [methyl-3H] labeled cell membranes 
to 1 M sodium borate, pH 11, for 10 and 20 min (which 
Table 1 
Methylated 21-23 kDa proteins of NlE 115 cells are membrane bound 
proteins 
Cellular fraction and treatment [methyl-3H] in 21-23 kDa 
proteins (dpm) 
Homogenate 2920 
Membranes 2840 
Washed membranes 2760 
Membranes treated with 1 M NaCl: 
Supernatant 160 
Pellet 2510 
Membranes treated with 1% NP-40: 
Supernatant 2710 
Pellet 30 
Confhmnt cells were labeled and fractionated as described in section 
2. Membranes were either used directly (membranes) or: (i) washed 
three times with 6 ml of the homogenization buffer; (ii) incubated for 
30 min at 4°C with either 1 M NaCl or 1% Nonidet NP-40, followed 
by a 100000 x g, 1 h spin to separate supernatants and pellet. Whole 
homogenate (460pg protein) or the equivalent amount of proteins in 
the various fractions were separated on gels and the amount of 
[methyl-3H] labeled 21-23 kDa proteins was determined in the vapor- 
phase equilibrium assay. 
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has been used to hydrolyze protein carboxyl methyl tein, n = 8 and 31800 f 2 800 dpm/mg membrane 
esters in many systems [S-11], failed to release the protein, n = 6; see also figs 1B and 2B). In pulse chase 
lmethyl-3H] groups incorporated into the 21-23 kDa experiments it was found that the [methyl-3H] labeled 
proteins. In a pulse-chase xperiment, a very small loss 21-23 kDa proteins in the DMSO-induced differen- 
of [methyl-3H] groups was detected even after 18 h tiated cells had a significant, though slow (half time of 
(fig.lC). 8-9 h) turnover (fig.2C). 
DMSO-induced differentiated cells (7 days in culture) 
were used for measurements of the incorporation of 
[methyl-3H] groups into proteins under the same condi- 
tions used for the confluent cells. The observed 
methylation pattern in these cells (fig.2A) and mem- 
branes (fig.2B) was similar to that observed in the con- 
fluent cells. Comparison between the extent of 
[methyl-3H] incorporation into the 21-23 kDa proteins 
of the confluent cells and of the DMSO-induced dif- 
ferentiated cells, revealed that it was higher in the latter 
(respectively 10650 & 2080 dpm/mg membrane pro- 
4. DISCUSSION 
Intact neuroblastoma NlE 115 cells methylate a 
group of 21-23 kDa membrane bound proteins. A 
3-fold increase was observed in DMSO-induced dif- 
ferentiated cells. Methylation of the 21-23 kDa proteins 
has characteristics typical of enzymatic reactions in 
which [methyl-3H] groups are incorporated into base- 
labile methylesters at free carboxyl groups. However, 
these protein methylesters how a relatively high degree 
of chemical and biological stability; unlike certain other 
protein carboxyl methylesters [6,7], they are not 
degraded at mild alkaline pH’s. The pulse-chase ex- 
periments also suggested biological stability of the 
21-23 kDa protein methylesters. After 18 h, there was 
only a small loss of methylated protein (- 25%) in the 
confluent cells and a slow turnover in the differentiated 
cells (- 7.5%). The differences in turnover, however, 
may be associated with the increased methylation 
observed in the differentiated cells. We do not think 
that they are related to methylesterase activity because, 
under the conditions used here, less than Solo of the 
radioactivity incorporated in 1 h was lost after chase for 
3 h (fig.lC and 2C). In this regard the methylated pro- 
teins of the neuroblastoma resemble the C-terminal 
~-carbox~ethylated cysteinyl p 21ra” protein, in which 
no methyl group turnover was detected 1141. The 21-23 
kDa methylated proteins of the neuroblastoma cells 
share similarities in molecular weights, membrane 
localization and stabilities with the methylated ras pro- 
teins [ 13,141, 23-29 kDa proteins of bovine rod outer 
segments [15] and 20-23 kDa proteins of macrophage 
RAW 264 cells [18]. Based on the common C-terminal 
cysteinyl methylation of the rod outer segments pro- 
teins and the ras proteins, Ota and Clarke [ 151 sug- 
gested that the former, like the normal ras proteins, 
would be functional G-proteins. This notion would be 
in line with the GTP-dependent methylation of the 
20-23 kDa macrophage proteins [ 181, if all of these pro- 
teins represent a family of closely related gene products. 
Perhaps the neuroblastoma methylated membrane pro- 
teins are also small G-proteins. The results with the 
neuroblastoma lso raise an important question regar- 
ding the reversibility of methylation of the 21-23 kDa 
proteins under physiological conditions. We suspect 
that these highly stable protein methylesters may either 
be demethylated by a methylesterase that might be ac- 
tivated by a specific stimulus, or that their metabolic 
fate includes cleavage which releases a methylated pep- 
tide. 
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Fig.2. ~~hylation of DMSO-indu~d differentiated NlE 115 cells’ 
proteins. Cells were labeled with [methyl-~H]m~hionine for 1 h in the 
absence (0) or in the presence (0) of 3-deaza-adenosine and 
homocysteine thiolactone (A,B) or for 1 h with [methyL3H]methio- 
nine which was followed by chase with DMEM (C). Experimental 
procedures and definitions are as in fig. 1. (A) Methylation pattern of 
whole cells proteins. (B) Methylation patterns of membrane proteins. 
(C) Turnover of the major peak of the 21-23 kDa methylated pro- 
teins. 
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